FIA
ALT icon

FNY Investment Advisers’s Altimmune ALT Stock Holding History

FNY Investment Advisers’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,000
Closed -$18K – 914
2025
Q3 		$18K Buy
+5,000
New +$19.3K 0.01% 700
2024
Q1 		– Sell
-3,171
Closed -$35K – 666
2023
Q4 		$35K Buy
+3,171
New +$13.2K 0.04% 217
2022
Q3 		– Sell
-2,730
Closed -$31K – 637
2022
Q2 		$31K Buy
+2,730
New +$16.8K 0.02% 278
2020
Q4 		– Sell
-6,500
Closed -$85K – 760
2020
Q3 		$85K Buy
+6,500
New +$130K 0.04% 225

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FNY Investment Advisers's ALT Position: Q4 2025 in Review

FNY Investment Advisers sold out of Altimmune (ALT) in Q4 2025, closing a stake of 5,000 shares — an estimated $18K sold.

FNY Investment Advisers first reported a position in ALT in Q3 2020 and held it in 4 quarters. The position peaked at $85K in Q3 2020. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • FNY Investment Advisers reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 5,000 Altimmune shares in Q4 2025, an estimated $18K.
  • FNY Investment Advisers first reported a position in Altimmune in Q3 2020 and held it in 4 quarters.
  • FNY Investment Advisers's Altimmune position peaked at $85K in Q3 2020.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.